Company Name
Fujian South Pharmaceutical Co., Ltd.
Year of Establishment
2001
Enterprise Size
300 to 349
Annual Turnover(USD)
choose not to disclose
Company Introduction
Fujian South Pharmaceutical Co., Ltd. (FSP) was established in 2001, located in Mingxi County, Fujian Province, China. Today, FSP has become an important cGMP manufacturer for oncology APIs in China. FSP cultivates 7,000 acres of Taxus Wallichiana (Taxus yunnanensis), and it is the largest commercial utilizing in China. FSP is the main supplier for natural Paclitaxel, semi-synthesis Paclitaxel, Docetaxel, 10-DAB III (Taxus Baccata and Taxus Wallichiana) in the world. FSP is a main supplier for Gemcitabine, Irinotecan and the patented technologies for Docetaxel, Imatinib, and Erloitnib, etc. FSP is strong in R&D, with a pathbreaking team in Shanghai R&D Center. We hold 6 PCT patents and 33 China patents for processing of taxanes, tabines and tinibs. FSP endeavors to become a well-known oncology pharmaceutical company in the world in next decade.
Main Competitive Advantages
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.southpharma.com
Other Competitive Advantages
Patents and Copyright
We hold 9 PCT patents and 39 China patents for processing of taxanes, tabines and tinibs.